within Pharmacolibrary.Drugs.S_SensoryOrgans.S01X_OtherOphthalmologicals.S01XA31_Pegcetacoplan;
model Pegcetacoplan 
   extends Pharmacolibrary.Drugs.ATC.S.S01XA31;

  annotation(Documentation(
    info ="<html><body><p>Pegcetacoplan is a complement C3 inhibitor, primarily used for the treatment of paroxysmal nocturnal hemoglobinuria (PNH). It is a pegylated cyclic peptide approved for clinical use, offering targeted therapy by inhibiting the complement cascade at the level of C3, thereby controlling hemolysis related to PNH.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters were reported in adults with PNH following subcutaneous administration.</p><h4>References</h4><ol><li><p>Versino, F, &amp; Fattizzo, B (2024). Complement inhibition in paroxysmal nocturnal hemoglobinuria: From biology to therapy. <i>International journal of laboratory hematology</i> 46 Suppl 1 43–54. DOI:<a href=&quot;https://doi.org/10.1111/ijlh.14281&quot;>10.1111/ijlh.14281</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/38622956/&quot;>https://pubmed.ncbi.nlm.nih.gov/38622956</a></p></li><li><p>Xu, B (2023). Novel targeted C3 inhibitor pegcetacoplan for paroxysmal nocturnal hemoglobinuria. <i>Clinical and experimental medicine</i> 23(3) 717–726. DOI:<a href=&quot;https://doi.org/10.1007/s10238-022-00830-3&quot;>10.1007/s10238-022-00830-3</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/35441351/&quot;>https://pubmed.ncbi.nlm.nih.gov/35441351</a></p></li><li><p>Crass, RL, et al., &amp; Langdon, G (2024). Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Analyses of Pegcetacoplan in Patients with Paroxysmal Nocturnal Hemoglobinuria. <i>Drugs in R&amp;D</i> 24(4) 563–573. DOI:<a href=&quot;https://doi.org/10.1007/s40268-024-00500-7&quot;>10.1007/s40268-024-00500-7</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/39612158/&quot;>https://pubmed.ncbi.nlm.nih.gov/39612158</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Pegcetacoplan;
